Welcome to Biolynce Academy!
Biolynce Academy is an unique eLearning platform where one can navigate through different courses and contents designed to deepen and update pharmaceutical, biotechnological and biomedical science knowledge.
It challenges the trainees to translate theory and professional routines into new real-life scenarios.
By doing this you position yourself to thrive in your career path in Life Sciences.
So, let yourself realize that you deserve more in your life and let's begin!
We believe that everyone has the right to new skills learning and self-improvement
What we do
Our Impact
Partnerships
Training with Quality
Open a whole world of education
CHECK THE CONTENTS OF THE COURSE
PHARMACOVIGILANCE FOR PHARMACISTS
MODULE 1— The Role of the Pharmacist in Drug Safety
Unit 1.1 - The Pharmacy as a Pillar of Pharmacovigilance
Unit 1.2 – What Pharmacovigilance Really Is
Unit 1.3 – European and National Legal ramework
Unit 1.4 – The Community Pharmacy as a Listening Post
Unit 1.5 – ADR, Adverse Event, Medication Error: not the Same Thing
MODULE 2 — Adverse Drug Reactions (ADRs)
Unit 2.1 - Classification of ADRs (Type A, B, C, D, E)
Unit 2.2 - Recognising An ADR In The Dispensing Context
Unit 2.3 - Risk Factors: Polypharmacy, Older Adults, Chronic Conditions
Unit 2.4 - ADRs vs. Therapeutic Failure vs. Drug Interactions
MODULE 3— Spontaneous Reporting — From Theory to Practice
Unit 3.1 - National spontaneous reporting systems across Europe
Unit 3.2 - Who Can And Should Report
Unit 3.3 - How To Complete A Report Step By Step
Unit 3.4 - What Happens After Reporting — The Information Cycle
Unit 3.5 - Practical Cases: When To Report And When Not To Report
MODULE 4 — Special Situations in Community Pharmacy
Unit 4.1 - How To Communicate Clearly With The Patient
Unit 4.2 - ADRs In Pregnant And Breastfeeding Women
Unit 4.3 - ADRs in paediatrics
Unit 4.4 - ADRs In Older Adults And Patients On Polypharmacy
Unit 4.5 - OTC Medicines And Supplements — Should These Be Reported Too?
Unit 4.6 - Vaccines — Post-Marketing Surveillance Reporting
MODULE 5 — Talking to Patients About ADRs — Without Making Them Panic
Unit 5.1 — How to Ask About ADRs Without Alarming the Patient
Unit 5.2 — Explaining ADRs in Plain Language
Unit 5.3 — The Patient Who Refuses to Report
Unit 5.4 — Internal Documentation in the Pharmacy
MODULE 6 — The Pharmacist, the Algorithm, and the Patient — Pharmacovigilance in the Age of AI
Unit 6.1 — A Pharmacovigilance Checklist For Dispensing
Unit 6.2 — How Many Reports Does Your Pharmacy Submit?
Unit 6.3 — Current Trends: AI, Reporting Apps, Real-World Data
Unit 6.4 — The Future Of Pharmacovigilance And The Pharmacist's Role
FINAL ASSESSMENT
CERTIFICATE OF COMPLETION
Unit 1.1 - The Pharmacy as a Pillar of Pharmacovigilance
Unit 1.2 – What Pharmacovigilance Really Is
Unit 1.3 – European and National Legal ramework
Unit 1.4 – The Community Pharmacy as a Listening Post
Unit 1.5 – ADR, Adverse Event, Medication Error: not the Same Thing
MODULE 2 — Adverse Drug Reactions (ADRs)
Unit 2.1 - Classification of ADRs (Type A, B, C, D, E)
Unit 2.2 - Recognising An ADR In The Dispensing Context
Unit 2.3 - Risk Factors: Polypharmacy, Older Adults, Chronic Conditions
Unit 2.4 - ADRs vs. Therapeutic Failure vs. Drug Interactions
MODULE 3— Spontaneous Reporting — From Theory to Practice
Unit 3.1 - National spontaneous reporting systems across Europe
Unit 3.2 - Who Can And Should Report
Unit 3.3 - How To Complete A Report Step By Step
Unit 3.4 - What Happens After Reporting — The Information Cycle
Unit 3.5 - Practical Cases: When To Report And When Not To Report
MODULE 4 — Special Situations in Community Pharmacy
Unit 4.1 - How To Communicate Clearly With The Patient
Unit 4.2 - ADRs In Pregnant And Breastfeeding Women
Unit 4.3 - ADRs in paediatrics
Unit 4.4 - ADRs In Older Adults And Patients On Polypharmacy
Unit 4.5 - OTC Medicines And Supplements — Should These Be Reported Too?
Unit 4.6 - Vaccines — Post-Marketing Surveillance Reporting
MODULE 5 — Talking to Patients About ADRs — Without Making Them Panic
Unit 5.1 — How to Ask About ADRs Without Alarming the Patient
Unit 5.2 — Explaining ADRs in Plain Language
Unit 5.3 — The Patient Who Refuses to Report
Unit 5.4 — Internal Documentation in the Pharmacy
MODULE 6 — The Pharmacist, the Algorithm, and the Patient — Pharmacovigilance in the Age of AI
Unit 6.1 — A Pharmacovigilance Checklist For Dispensing
Unit 6.2 — How Many Reports Does Your Pharmacy Submit?
Unit 6.3 — Current Trends: AI, Reporting Apps, Real-World Data
Unit 6.4 — The Future Of Pharmacovigilance And The Pharmacist's Role
FINAL ASSESSMENT
CERTIFICATE OF COMPLETION
